ArticleCureus2025
Bilirubin as a Diagnostic Factor in Acute Appendicitis.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundAcute appendicitis is one of the most common surgical emergencies. The decision for surgical management can be challenging, especially in young patients and in females. There have been many trials to have a scoring system to help the surgical decision with many laboratory and clinical inputs, such as WBC count, C-reactive protein (CRP), and fever. Objective: In this study, we tried to determine if bilirubin could be used as a diagnostic factor in acute appendicitis to help make the surgical decision. Methods: A retrospective observational study was conducted, including all the patients who presented to Warwick Hospital's general surgery on-call service between January and May 2024 with a complaint of acute right lower abdominal pain. All the data from patients' records underwent data analysis. Results: Around 360 patients were identified (n=360), 103 (28.6%) had an appendectomy, 36 (10%) of all the patients had hyperbilirubinemia, and 26 (72.2%) of the patients who had an appendectomy had hyperbilirubinemia. Bilirubin has a specificity of 96.2% and a sensitivity of 27.7% for the diagnosis of acute appendicitis in the acute presentation. Conclusions: Bilirubin can be used as a highly specific factor for the diagnosis of acute appendicitis in acute right lower abdominal pain to support the surgical decision and to prevent the complications caused by the delay in the surgical management.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.